MMMaha Hosni Morsi

Maha Hosni Morsi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maha Hosni Morsi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum IL-38 and the rs7599662 polymorphism: novel biomarkers for pediatric idiopathic nephrotic syndrome

    by Sherin Khamis Hussein, Maha Hosni Morsi, Omayma O. Abdelaleem, Doaa Ezzat Sayed Ahmed, Doha Elsayed Ahmed Hassanein, Marwa A. Ali, Shaimaa Abdelbadie, Ahmed Mohamed Gamal EL Din Wahba, Asmaa Younis Elsary, Heba Safar, et al.

    Background: Idiopathic nephrotic syndrome (INS) is the most common chronic glomerular disorder in children and is characterized by a variable response to corticosteroid therapy. Interleukin-38 (IL-38), an anti-inflammatory cytokine, and its gene polymorphisms may influence disease susceptibility and treatment outcomes. This study investigated the associations between serum IL-38 levels, the rs7599662 gene polymorphism, and disease presence in pediatric INS patients. Methods: This case‒control study included 88 pediatric INS patients and 74 age- and sex-matched healthy controls. Patients were categorized as steroid sensitive (50%), steroid dependent (25%), or steroid resistant (25%). Serum IL-38 was measured by ELISA, and rs7599662 (C/T) genotyping was performed via real-time PCR. Statistical analyses included nonparametric tests, chi-square tests, Spearman correlation, and receiver operating characteristic (ROC) curve analysis. Results: Serum IL-38 levels were significantly lower in patients than in controls (17.9 ± 11.4 vs. 38.8 ± 35.6 ng/L, p < 0.001). IL-38 was negatively correlated with age ( r = -0.28, p = 0.01), systolic blood pressure ( r = -0.28, p = 0.01), and urinary protein ( r = -0.38, p = 0.001). ROC analysis revealed that IL-38 had moderate diagnostic performance (AUC = 0.687, p < 0.001), with 73.7% sensitivity and 63.8% specificity at a cutoff of 18.773 ng/L. The CT genotype was significantly more common in patients ( p = 0.003), with a protective association observed for the TT genotype under a recessive model ( p = 0.002). Serum IL-38 levels did not differ among steroid-sensitive, dependent, or resistant subgroups ( p = 0.32). Conclusion: This first report of reduced serum IL-38 and the rs7599662 polymorphism in pediatric INS suggests a role for impaired anti-inflammatory responses in disease pathogenesis. Serum IL-38 shows promise as a diagnostic biomarker and may reflect disease pathophysiology, but does not predict steroid responsiveness. These hypothesis-generating findings require validation in larger, prospective, multicenter studies to establish their clinical utility. The primary value of this work lies in generating testable hypotheses for future confirmatory studies rather than providing definitive mechanistic answers.

  • Open Access

    Unveiling the Disparities in the Field of Precision Medicine: A Perspective

    by Maha Hosni Morsi, Bashaer Elawfi, Saad Ashraf Alsaad, Ahmed Nazar, Hamed Abdelma'ABoud Mostafa, Sara Adel Awwad, Maya Magdy Abdelwahab, Husam Tarakhan, Ehssan Baghagho

    Background and Aim: Precision medicine prescribes medication based on genetic data, social history, and environment, offering more effective care. This article presumes that many disparities shatter this promise for numerous groups. The article discusses the challenges of personalized medicine in relation to disparities, proposes solutions, and introduces strategies to address these issues.Methods: A comprehensive literature review was done to understand precision medicine, its implementation challenges, and possible answers. Academic databases, including Google Scholar, PubMed, and Scopus, were searched for relevant studies and peer‐reviewed articles. Peer‐reviewed precision medicine articles in oncology, internal medicine, public health, and obstetrics and gynecology were included to provide a broad and interdisciplinary perspective.Results: The concept of precision medicine needs to be implemented throughout many levels of society and healthcare systems around the world. Access to genomic data is limited in high‐income countries, and socioeconomic disparities hinder healthcare equality, particularly for low‐income individuals or those without insurance. The digital divide, lack of education, ethical concerns, and regulatory frameworks contribute to disparities in personalized medicine. We believe that health equity will be achieved by addressing these discrepancies and suggesting some strategies to overcome them.Conclusion: Precision medicine has successfully treated and helped in the early detection of many diseases, like severe asthma, cancer, and type 1 diabetes. Socioeconomic position, education, data, access, and regulatory frameworks prevent minorities and low‐income populations from using it. For instance, lack of awareness and other inequalities in access to precision medicine limit T1DM HLA typing and autoantibody surveillance. These discrepancies must be addressed to improve minority and low‐income T1DM patients' outcomes. The patient‐oriented strategy is cost‐effective and includes benefits through education, genetic data diversity promotion, and increased access, but regulatory frameworks are essential.


  • Assessing the Dynamic Interplay of Omicron Spike Protein Receptor-Binding Domain (S-RBD) IgG Antibody Responses in Hospitalized COVID-19 Patients in Egypt: An Original Article

    by Hoda Saed, Lamiaa Gaber Zake, Sabrin Abdullah Mohamed, Reda Mohamed Abdallah Elghamry, Lobna A. Alqurashi, Maha Hosni Morsi

    Background: The SARS-CoV-2 Omicron variant (B.1.1.529) has raised concerns the reason behind them being having numerous spike protein mutations and potential impact on disease severity and immune response. This research set out to determine the level of anti-SARS-CoV-2 IgG antibodies targeting the receptor-binding domain (S-RBD) and correlate the antibody levels with COVID-19 infection severity and outcomes. Methods: This prospective cohort study included 61 Sinopharm/Sinovac-vaccinated individuals who came down with SARS-CoV-2 infection. Patients were categorized as moderate, severe, or critically ill. Omicron,B.1.1.529 IgG (anti-S-RBD) antibody concentrations were measured using ELISA at admission and 3 weeks later, correlations with clinical parameters were analyzed. Results: The median antibody concentration at ICU admission for all patients (n=61) was 30.2 ng/ml . The median antibody concentration after 3 weeks for survivor patients (n=43) was 58 ng/ml. A statistically significant negative correlation has been determined between antibody concentration and age. Antibody levels significantly correlated with COVID-19 severity and patient outcomes. The optimal cutoff for predicting mortality was ≤19.49 ng/ml (sensitivity 50%, specificity 72.1%), while the cutoff for critically ill disease was ≤18.43 ng/ml (sensitivity 100%, specificity 87.8%). Conclusion: Serial (S-RBD) IgG antibody levels could function as a crucial prognostic marker for recognizing patients at risk of developing critical illness. The study highlights the future potential utility of antibody measurements in clinical risk stratification and patient management particularly when considered alongside vaccination history and previous infections. Further long term follow up studies with genetic verification are needed to establish causal relationships.

  • Open Access

    Molecular and Hematological Analysis of Alpha Thalassemia in Middle East Patients; A Cross-Sectional Retrospective Study

    by Maha H. Morsi, Hayaa M. Alhuthali, Heba M. Elmasry, Shmoukh Alghuraibi, Ola Elgaddar, Amal F. Gharib, Doha E. Ahmed

    Hemoglobinopathy is the most frequent genetic illness worldwide. Alpha thalassemia is common in Middle East. The loss of one or both HBA genes in the -globin gene cluster causes alpha-thalassemia. The countrywide prevalence and distribution of alpha globin gene mutations must be studied. Molecular screening and detection improve thalassemia-risk prenatal diagnosis and genetic counselling. This article compares different alpha thalassaemia mutations molecular and haematological characteristics in the Middle East. This cross-sectional retrospective analysis was carried out from September 2022 to June 2023. A study investigated 200 samples of alpha thalassemia patients in the Middle East using Reversed Dot Blot Hybridization-based multiplex-PCR to screen for 21 known α-globin gene abnormalities. We found 17 alpha-globin gene variants. The first prevalent anomaly was (deletional) 3.7 homozygous (34.5%), and the second was 3.7 heterozygous (18.5%). The genotype (--MED αα /α2 poly A2) was strongly linked with lower hemoglobin and RBCs levels in α-thalassemia (p-value of 0.027 and 0.042 respectively).The most prevalent alpha thalassemia abnormality is -α3.7/ -α3.7. Alleles show diversity in Middle Eastern populations. Even genotype-matched people had different haematological parameters. Haematological criteria cannot uniquely characterize any alpha thalassaemia mutation.

  • Open Access

    Nootkatone Mitigated Melamine-Evoked Hepatotoxicity by Featuring Oxidative Stress and Inflammation Interconnected Mechanisms: In Vivo and In Silico Approaches

    by Ola A. Habotta, Ahmed Abdeen, Ali B. Roomi, Afnan I. Elgndy, Safwa M. Sorour, Maha H. Morsi, Kamal M. Kamal, Samah F. Ibrahim, Doaa Abdelrahaman, Liana Fericean, et al.

    Melamine (ML) is a common environmental contaminant, commonly used in food fraud, representing a serious health hazard and jeopardizing human and animal health. Recently, nootkatone (NK), a naturally occurring sesquiterpenoid, has garnered considerable attention due to its potential therapeutic advantages. We investigated the potential mechanisms underlying the protective effects of NK against ML-induced liver injury in rats. Five groups were utilized: control, ML, NK10, ML-NK5, and ML-NK10. ML induced substantial hepatotoxicity, including considerable alterations in biochemical parameters and histology. The oxidative distress triggered by ML increased the generation of malondialdehyde (MDA) and nitric oxide (NO) and decreased levels of reduced glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD) activities. In addition, decreased expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) and increased nuclear factor kappa beta (NF-κB) expression levels were observed in hepatocytes, which indicated the occurrence of inflammatory changes following ML exposure. These alterations were alleviated by NK supplementation in a dose-dependent manner. The data revealed that the favorable effects of NK were attributed, at least in part, to its antioxidant and anti-inflammatory properties. Moreover, our results were supported by molecular docking studies that revealed a good fit and interactions between NK and antioxidant enzymes. Thus, the current study demonstrated that NK is a potential new food additive for the prevention or treatment of ML-induced toxicity.


  • Open Access

    Collagen triple-helix repeat containing 1 (CTHRC1) protein in rheumatoid arthritis patients: Relation to disease clinical, radiographic and ultrasound scores

    by Noha H. Ibrahim, Nashwa I. Hashaad, Noha M. Abdelnaser, Maha H. Morsi, Iman M. Fawzy, Rasha Abdel Hameed, Shaza A. Abdul Basset


  • Open Access

    Liver injury with COVID-19: laboratory and histopathological outcome—systematic review and meta-analysis

    by Sherine A. Mohammed, Khalid M. Eid, Felix Emeka Anyiam, Hazem Wadaaallah, Muhamed Ahmed Mahmoud Muhamed, Maha Hosni Morsi, Nesrine Ben Hadj Dahman

    Background: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been predominantly linked to respiratory distress syndrome, but hepatic injury has also been reported. The mechanism of liver injury is poorly understood. This review aimed to systematically review the current data through laboratory tests and liver tissue pathology to ascertain the correlation of liver involvement in SARS-CoV-2 infection patients. Methods: The PubMed, Scopus, Science Direct, and Web of Science databases were searched systematically. We included peer-reviewed published papers available online as clinical cases, cohort studies, and retrospective studies, for both in vitro and in vivo human studies. Independent extraction of the data was done by two independent authors. Results: A total of 15 articles were finally included in the systematic review process and meta-analysis after exclusion of studies that did not meet the eligibility criteria, summarized in a PRISMA flow diagram. The meta-analysis showed that patients with underlying abnormal liver function and/or histopathological finding had a statistically significant 8.08 times higher odds of severe COVID-19 outcomes when data from the individual studies were pooled (OR 8.08; 95% CI,3.43, 19.03; p = 0.00001). Five of these studies showed histopathological changes on autopsy from cases with severe COVID-19, and in four of these five studies, the histopathology was associated with a history of abnormal liver function after affection with COVID-19. Short conclusion: The study observed that the severity of COVID-19 was associated with more patients with aberrant liver function tests.